Provided by Tiger Trade Technology Pte. Ltd.

Sagimet Biosciences Inc.

11.06
+0.20001.84%
Post-market: 11.060.00000.00%19:30 EDT
Volume:937.70K
Turnover:10.47M
Market Cap:687.47M
PE:-8.86
High:11.45
Open:10.75
Low:10.67
Close:10.86
52wk High:11.45
52wk Low:4.50
Shares:62.16M
Float Shares:55.78M
Volume Ratio:0.75
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2490
EPS(LYR):-1.5800
ROE:-24.37%
ROA:-16.41%
PB:2.68
PE(LYR):-7.00

Loading ...

BRIEF-Sagimet Biosciences Reports First Quarter 2026 Financial Results And Provides Corporate Updates

Reuters
·
May 12

Sagimet Biosciences Q1 EPS $(0.33) Beats $(0.36) Estimate

Benzinga Earnings
·
May 12

Sagimet Q1 FY26 net loss narrows to $10.7 million; R&D expense drops to $7 million

Reuters
·
May 12

Press Release: Sagimet Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Dow Jones
·
May 12

Sagimet plans U.S. Phase 3 denifanstat acne trial start in H2 2026

Reuters
·
May 11

Sagimet Biosciences to Present Mechanism of Action Data for its FASN Inhibitors at the Society for Investigative Dermatology in Chicago

GlobeNewswire
·
May 11

Sagimet Biosciences Inc expected to post a loss of 37 cents a share - Earnings Preview

Reuters
·
May 08

Sagimet Biosciences Inc : Canaccord Genuity Raises Target Price to $49 From $28

THOMSON REUTERS
·
May 05

Sagimet Biosciences Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
May 04

Sagimet Biosciences, Inc. Class A (SGMT) Receives a Buy from JonesTrading

TIPRANKS
·
May 04

Oppenheimer Adjusts Price Target on Sagimet Biosciences to $33 From $28, Maintains Outperform Rating

MT Newswires Live
·
May 01

Sagimet Biosciences Is Maintained at Buy by Guggenheim

Dow Jones
·
Apr 30

Sagimet Biosciences price target lowered to $25 from $27 at Guggenheim

TIPRANKS
·
Apr 29

3 Penny Stocks to Watch Now, 4/28/26

TIPRANKS
·
Apr 29

Sagimet Biosciences holds a conference call

TIPRANKS
·
Apr 29

BRIEF-Sagimet Biosciences Offers 29.17 Million Shares Of Series A Common Stock - SEC Filing

Reuters
·
Apr 28

Sagimet Biosciences Inc - Offering 29.17 Mln Shares of Series a Common Stock - SEC Filing

THOMSON REUTERS
·
Apr 28

NASD Most Active Issues

Dow Jones
·
Apr 28

Top Midday Gainers

MT Newswires Live
·
Apr 28

Why Is Sagimet Biosciences Stock Trading Higher On Monday?

Benzinga
·
Apr 28